3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
29
Pain, Postoperative
10
Colorectal Neoplasms
9
Neoplasms
8
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Melanoma
5
Ovarian Neoplasms
4
Hemorrhage
4
Head and Neck Neoplasms
4
Agnosia
4
Rectal Neoplasms
3
Neurotoxicity Syndromes
3
Nasopharyngeal Carcinoma
3
Myoma
3
Multiple Endocrine Neoplasia Type 1
3
Meningioma
3
Lymphoma, Non-Hodgkin
3
Leiomyoma
3
Glioblastoma
3
Delirium
3
Colonic Neoplasms
3
Chronic Pain
3
Warts
2
Uterine Cervical Neoplasms
2
Stomatitis
2
Skin Neoplasms
2
Interventions
Exercise
6
Transcranial Direct Current Stimulation
4
Neuropsychological Tests
4
Walking
3
Memantine
3
Tablets
2
Standard of Care
2
Patient Reported Outcome Measures
2
Methods
2
Electroencephalography
2
Donepezil
2
Cognitive Behavioral Therapy
2
mazdutide
1
lime
1
enzalutamide
1
blueberry extract
1
beta Carotene
1
acetaminophen, aspirin, caffeine drug combination
1
Vitamin E
1
Vitamin D
1
Ultraviolet Therapy
1
Transcranial Magnetic Stimulation
1
Time
1
Therapeutics
1
Tai Ji
1
Surveys and Questionnaires
1
Sugars
1
Sodium Chloride
1
Sirolimus
1
Silymarin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cognitive Dysfunction
×
Sodium Chloride
×
Clear all
NCT04395339
2024-08-01
GLORY
Sun Yat-sen University
Phase 3
Terminated
51 enrolled